PharmacyCodes



Oxyde Arsenieux [ISO-French] en es it fr

Oxyde Arsenieux [ISO-French] Brand names, Oxyde Arsenieux [ISO-French] Analogs

Oxyde Arsenieux [ISO-French] Brand Names Mixture

  • No information avaliable

Oxyde Arsenieux [ISO-French] Chemical_Formula

As2O3

Oxyde Arsenieux [ISO-French] RX_link

http://www.rxlist.com/cgi/generic2/arsenic.htm

Oxyde Arsenieux [ISO-French] fda sheet

Oxyde_Arsenieux_[ISO-French] FDA

Oxyde Arsenieux [ISO-French] msds (material safety sheet)

Oxyde Arsenieux [ISO-French] Synthesis Reference

No information avaliable

Oxyde Arsenieux [ISO-French] Molecular Weight

197.841 g/mol

Oxyde Arsenieux [ISO-French] Melting Point

No information avaliable

Oxyde Arsenieux [ISO-French] H2O Solubility

No information avaliable

Oxyde Arsenieux [ISO-French] State

Solid

Oxyde Arsenieux [ISO-French] LogP

No information avaliable

Oxyde Arsenieux [ISO-French] Dosage Forms

Tablet

Oxyde Arsenieux [ISO-French] Indication

For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression

Oxyde Arsenieux [ISO-French] Pharmacology

Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.

Oxyde Arsenieux [ISO-French] Absorption

No information avaliable

Oxyde Arsenieux [ISO-French] side effects and Toxicity

Symptoms of overdose include convulsions, muscle weakness and confusion.

Oxyde Arsenieux [ISO-French] Patient Information

No information avaliable

Oxyde Arsenieux [ISO-French] Organisms Affected

Humans and other mammals